Neukine 300 mcg – Composition, Uses and Medicine Enquiries
Product Overview
Neukine 300 mcg contains Filgrastim, a granulocyte colony-stimulating factor that helps bone marrow produce neutrophils, a type of white blood cell important for fighting infection.
Doctors may prescribe it to reduce the duration of neutropenia following certain chemotherapy regimens or for other approved conditions associated with low neutrophil counts.
It does not directly treat cancer or replace treatment for an active infection.
The injection requires clinician-directed timing, blood-count monitoring and assessment of possible adverse effects.
The exact concentration, formulation and injection presentation should be confirmed against the actual manufacturer-labelled packaging before publishing this product page.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Filgrastim | 300 mcg |
Product Name: Neukine 300 mcg
Generic Name: Filgrastim
Brand Name: Neukine
Strength: 300 mcg
Formulation: To be verified against the actual manufacturer-labelled product.
Please verify the exact formulation, concentration, injection presentation and manufacturer details against the original product packaging before publishing this product page or proceeding with an enquiry.
Therapeutic Category and Indication
Neukine 300 mcg belongs to the hematopoietic growth factor category and is classified as a G-CSF (granulocyte colony-stimulating factor).
Its clinical use relates to the prevention or treatment of selected chemotherapy-related neutropenia.
Doctors may prescribe it to reduce the duration of neutropenia following certain chemotherapy regimens or for other approved conditions associated with low neutrophil counts.
It does not directly treat cancer or replace treatment for an active infection.
Treatment decisions depend on diagnosis, patient-specific factors, coexisting conditions, interactions and the applicable approved product information.
The listed indications are a general overview, not a substitute for a prescriber’s assessment. The exact approved uses and restrictions should be checked against the product’s current local prescribing information.
Administration Information
Neukine should be administered by the prescribed subcutaneous or intravenous route only after clinical instruction.
Timing relative to chemotherapy is important.
Patients should follow the prescribed blood-count monitoring schedule and should never alter the administration schedule independently.
The prescribed schedule, duration, missed-dose instructions and monitoring requirements must be provided by the treating clinician.
Patients should not start, switch or stop prescription therapy on the basis of website information.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: Neukine 300 mcg
- Generic Name: Filgrastim
- Brand Name: Neukine
- Strength: 300 mcg
- Therapeutic Category: Hematopoietic Growth Factor
- Medicine Class: G-CSF
- Indication: Prevention or treatment of selected chemotherapy-related neutropenia.
- Dosage Form: Injection — exact formulation to be verified.
The dosage form, concentration and pack size must be matched to the actual manufacturer-labelled presentation.
Available packaging, batch identification, expiry date and remaining shelf life may vary and should be confirmed by an authorised supplier before any transaction.
No pack quantity, stock position or export eligibility is guaranteed by this listing.
Prescription and Patient Safety
Neukine 300 mcg is a prescription medicine that requires appropriate clinical supervision.
The injection requires clinician-directed timing, blood-count monitoring and assessment of possible adverse effects.
Timing relative to chemotherapy is important, and patients should never alter the prescribed schedule independently.
It does not directly treat cancer or replace treatment for an active infection.
The exact precautions, monitoring requirements and possible adverse effects should be checked against the current approved product information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal receives medicine-related enquiries and may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.
Medinglobal does not itself manufacture, dispense, sell or export this medicine.
Availability, prescription requirements, lawful supply routes, supporting documents and any destination-country restrictions must be confirmed by the relevant authorised provider.
Submission of an enquiry is not a commitment or guarantee of supply.
How to Submit a Neukine 300 mcg Enquiry
To help identify the requested product, include the following details when submitting an enquiry:
- Product or brand name: Neukine 300 mcg.
- Generic name: Filgrastim.
- Required strength and dosage form.
- Required quantity.
- Destination country.
- Whether the request is for an individual patient or a healthcare institution.
- Valid prescription or other supporting documentation, where required.
Medinglobal may refer the enquiry to an appropriately authorised independent partner for verification and response.
Any subsequent transaction is subject to the partner’s own legal, clinical and regulatory checks.
Frequently Asked Questions
What is Neukine 300 mcg used for?
Neukine 300 mcg is associated with the prevention or treatment of selected chemotherapy-related neutropenia. Eligibility and approved indications depend on the specific product label and clinician assessment.
What does Neukine 300 mcg contain?
The supplied product information identifies Filgrastim 300 mcg. The exact formulation and injection presentation should be verified against the original product packaging.
Does Neukine 300 mcg directly treat cancer?
No. Filgrastim helps bone marrow produce neutrophils. It does not directly treat cancer or replace treatment for an active infection.
How is Neukine 300 mcg administered?
It is administered by the prescribed subcutaneous or intravenous route after clinical instruction.
Can I use this medicine without medical advice?
No. Prescription medicines and specialist therapies require qualified clinical oversight.
Can international patients enquire through Medinglobal?
Enquiries may be submitted, but lawful coordination and any supply depend on authorised partners and applicable local rules.
Does Medinglobal sell or dispense Neukine 300 mcg directly?
No. Medinglobal receives medicine-related enquiries and may help communicate with independent, appropriately authorised pharmaceutical suppliers or service providers. It does not itself manufacture, dispense, sell or export this medicine.
Reviews
There are no reviews yet.